Navigation Links
NicOx Reports First Quarter 2008 Financial Results
Date:5/14/2008

in these programs are revised periodically, if necessary. The payments received from Pfizer for the funding of the research activities are deferred over a period of 12 months from the date of invoice.

Operating expenses

Consolidated operating expenses were euro 17.5 million for the three months ended March 31, 2008, compared to euro 10.1 million for the three months ended March 31, 2007 (adjusted to reflect the reclassification of the research tax credit subsidies into other income as indicated below), of which 87% was attributable to research and development expenses and 13% to selling and administrative expenses in the first quarter of 2008, compared to 79% and 21% respectively in the first quarter of 2007.

Research and development expenses reached euro 15.1 million during the first quarter of 2008, compared to euro 8 million during the same period in 2007 (including euro 0.5 million allocated to cost of sales in 2008 and euro 0.6 million in 2007). These expenses are primarily due to the costs associated with the phase 3 development of naproxcinod, such as expenses related to contract research organizations and suppliers involved in naproxcinod's clinical development and manufacturing activities. At this time, the cost of sales principally corresponds to the expenses incurred by NicOx in performing research activities under the contracts signed with Pfizer and Merck. On March 31, 2008, the Company employed 92 people in research and development, compared to 72 people on March 31, 2007.

Administrative and selling expenses totaled euro 2.3 million in the first quarter of 2008, compared to euro 2.1 million in the first quarter of 2007. General and administrative expenses were euro 1.5 million during the three months ended March 31, 2008 and were primarily the result of personnel expenses in administrative and financial functions, as well as the remuneration of corporate officers, including stock option, bonus share and warrant attributions
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program
2. Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year
3. IRIDEX Reports First Quarter 2008 Financial Results
4. Cardiome Reports First Quarter Results
5. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
6. Health Plan Execs Receive Smaller Bonuses as Companies Push Performance-Based Pay, HPW Reports; Hanway Tops Others in Total Compensation
7. TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments
8. Med-Emerg International Inc. reports improved income from continuing operations
9. NxStage Medical Reports First Quarter 2008 Results
10. MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results
11. ULURU Inc. Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 ... review recently updated by Vkool.com, this is ... how to treat some common types of ... and internal hemorrhoids ,     Young children ... with hemorrhoids ,     Very large hemorrhoids ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 According ... review recently updated by Vkool.com, this is a ... range of natural and safe remedies for ... 8 chapters, including:,     Chapter 1: ...     Chapter 2: Learn About Liver Basics , ...
(Date:7/24/2014)... Journal of Oral Implantology —Success of ... of the alveolar ridge—an indication of the amount of ... methods exist, each with their own advantages, to determine ... is highlighted as a strategy for treating horizontally collapsed ... a comparison of two commonly used techniques , ...
(Date:7/24/2014)... PROVIDENCE, R.I. [Brown University] The U.S. Preventive ... lung screening for people at high risk for ... that many patients will have positive results on ... on further testing. Many policymakers have expressed concern ... to become needlessly upset. A new study of ...
(Date:7/24/2014)... Voted one of the most reliable ... BellasDress focuses on providing its new and old customers ... the company has announced its new collection of high ... is created according to the latest fashion trends. Additionally, ... 68% off. , As a matter of fact, high ...
Breaking Medicine News(10 mins):Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 3Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 2Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 3Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 2Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 3Health News:Informed consent: False positives not a worry in lung cancer study 2Health News:Informed consent: False positives not a worry in lung cancer study 3Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2
... epic, a prince donates his youth to his father so that ... kind of help is at hand now. For scientists say they ... ageing process. And by manipulating that gene perhaps one could live ... in extending the lifespan of animals that are subjected to a ...
... According to the latest on breast-feeding, there is no hard and ... Most young mothers would be more than glad to ... feeding, can prove too painful for motherly feelings to override. ... a horrendous time trying to breastfeed when her daughter Deborah was ...
... nurse to avoid common errors which effect 1in 10 patients. ... workers help spread disease to unexpected quarters. ,The ... the world and lessen the number of health care related ... in both developed and developing countries. ,The nine ...
... higher levels of calcium and vitamin D are significantly more ... damage that can increase risk of cognitive impairment, dementia, ... co-investigators from Duke and the University of North Carolina examined ... (79 men, 153 women) between the ages of 60 and ...
... epidemic diseases has entered the phase of clinical experiments, claimed ... that rely on antigen or antibody test, the new technology ... or RNA, to confirm epidemic diseases such as hepatitis or ... of US National Institutes of Health (NIH). ,Xiang ...
... that can enable the blind to hear what they cannot see ... reads texts through an embedded system and converts them into voice ... it can only read text, but later it is likely to ... team that took six months to develop the device and the ...
Cached Medicine News:Health News:Gene Responsible for Ageing Process Discovered and Calorie Restriction Could Help 2Health News:New Research Promises To Take The Pain Off Breast Feeding 2Health News:New Research Promises To Take The Pain Off Breast Feeding 3Health News:UN Agencys Checklist on Health Care Error 2Health News:Higher Intake of Calcium and Vitamin D Linked With Brain Lesions in Older People 2
(Date:7/24/2014)... 2014 Omnicell, Inc. (NASDAQ: ... supply management solutions and analytics software for healthcare ... to discuss the Company,s Second Quarter 2014 financial ... earnings conference call and webcastWhen: , July ... chairman, president and chief executive officer ...
(Date:7/24/2014)... 24, 2014  IGI Laboratories, Inc. (NYSE MKT: IG), a ... announced its financial results for the second quarter ended June ... , Total revenues of $6.5 million in the second quarter ... in 2013 , Total revenues of $13.3 million for ... 78% over the same period in 2013 , Total ...
(Date:7/24/2014)... LOS ANGELES , July 24, 2014 Many ... what they can do to ensure that their practice will ... dentists purchase the basic supplies they use the most can ... other, and many dentists have recently discovered that purchasing ... and loss. According to successful dentists across ...
Breaking Medicine Technology:Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7Dental Supplies Online is Key to Dental Success...Really! 2
... /PRNewswire/ -- PRA International, a leading Clinical Research ... during the 8th Annual Partnerships in Clinical Trials 2009 to ... Trade Centre in Rotterdam, The Netherlands. PRA operational and ... exhibiting at booth number 32. , On 4 November, PRA,s ...
... Shire plc (LSE: SHP, NASDAQ:,SHPGY) the global specialty biopharmaceutical company, announces results for,the three months to September 30, 2009. , , ... ... sales ... Product sales from core products(2) $532 ...
Cached Medicine Technology:PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009 2Shire Continues to Deliver Excellent Growth From Core Products 2Shire Continues to Deliver Excellent Growth From Core Products 3Shire Continues to Deliver Excellent Growth From Core Products 4Shire Continues to Deliver Excellent Growth From Core Products 5Shire Continues to Deliver Excellent Growth From Core Products 6Shire Continues to Deliver Excellent Growth From Core Products 7Shire Continues to Deliver Excellent Growth From Core Products 8Shire Continues to Deliver Excellent Growth From Core Products 9Shire Continues to Deliver Excellent Growth From Core Products 10Shire Continues to Deliver Excellent Growth From Core Products 11Shire Continues to Deliver Excellent Growth From Core Products 12Shire Continues to Deliver Excellent Growth From Core Products 13Shire Continues to Deliver Excellent Growth From Core Products 14Shire Continues to Deliver Excellent Growth From Core Products 15Shire Continues to Deliver Excellent Growth From Core Products 16Shire Continues to Deliver Excellent Growth From Core Products 17Shire Continues to Deliver Excellent Growth From Core Products 18Shire Continues to Deliver Excellent Growth From Core Products 19Shire Continues to Deliver Excellent Growth From Core Products 20Shire Continues to Deliver Excellent Growth From Core Products 21Shire Continues to Deliver Excellent Growth From Core Products 22Shire Continues to Deliver Excellent Growth From Core Products 23Shire Continues to Deliver Excellent Growth From Core Products 24Shire Continues to Deliver Excellent Growth From Core Products 25Shire Continues to Deliver Excellent Growth From Core Products 26Shire Continues to Deliver Excellent Growth From Core Products 27Shire Continues to Deliver Excellent Growth From Core Products 28Shire Continues to Deliver Excellent Growth From Core Products 29Shire Continues to Deliver Excellent Growth From Core Products 30Shire Continues to Deliver Excellent Growth From Core Products 31Shire Continues to Deliver Excellent Growth From Core Products 32Shire Continues to Deliver Excellent Growth From Core Products 33
... lens, doctors have to make a trade off ... Now, with the Digital Wide Field lens ... both in one lens. This lens provides ... non-contact lens paired with the higher magnification required ...
... The Stryker Wedge Suture Anchors are titanium ... and styles. The Wedge anchors are simple ... and OR staff. The following sizes and ... Suture, 5.0mm Single Eyelet 2 Sutures, 5.0mm ...
... Suture Anchor is a 3.0mm single loaded ... (PLLA). The anchor barb catches on the ... until it "breaks" free. The small size ... also frequently used in rotator cuff repair ...
... absorbable co-polymer synthesized from all-natural ingredients: ... acid. Unlike the homopolymers in common ... (PLLA) or 100% poly-glycolic acid (PGA), ... crystallinity), meaning that its degradation is ...
Medicine Products: